Research Library

Drug companies that bypass distributors and offer generics directly to patients, like the Mark Cuban Cost Plus Drug Company, could disrupt the pharmaceutical supply chain and ultimately save thousands of lives.

"This pandemic and looming economic crisis will affect all of us ... The sooner we relearn how to set aside our differences and unite during this difficult moment, the stronger we will emerge from it," writes former Secretary James A. Baker, III.

Coronavirus cases in Texas may grow as the state expands COVID-19 screening and the consequences of delayed decisions to limit public interactions set in. "No one should be surprised lim or panic as the figures roll out," write the authors in the Baker Institute Blog.

In the second of a series of blogs on the coronovirus outbreak, the authors sound a note of cautious optimism: "We hope for a relatively optimistic outlook for the COVID-19 pandemic in the United States, with the quick realization of all modifying interventions: earlier and broader testing, strict preventive hygienic and societal measures, a safe and effective vaccine, and effective therapies to treat the virus."  Read more at the Baker Institute Blog.

The COVID-19 outbreak has now reached pandemic proportions, threatening the health of millions worldwide and adversely affecting the international economy. Understanding the status of COVID-19, its potential impact in the U.S., and the needed preventive measures could save many lives.

James A. Baker, III, and George P. Shultz — both former secretaries of state and Treasury secretaries — offer "A Conservative Answer to Climate Change" in a commentary for The Wall Street Journal.

High cancer drug prices reduce access to therapy, cause treatment abandonment and financial bankruptcies, as well as severe emotional and family distress.

The 340B Drug Pricing Program, which allows uninsured or low-income patients to buy prescription drugs at discounted prices, is under attack.

In this commentary, the authors examine the roots of the United States’ reluctance to embrace universal health care, concluding that it "is neither sound nor ethical in a nation that promulgates fairness and equal opportunity" to deny coverage.